PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sopheon Announces Agreement to Acquire Alignent Software

11 Jun 2007 14:30

Sopheon, the international software and services company,announced today that it has signed a definitive agreement to acquireAlignent Software Inc. The cash-based transaction is expected to becompleted on or about June 18, 2007. £ Based in California, Alignent is one of only a few suppliersworldwide that specializes in the provision of advanced product andtechnology roadmapping software for complex global companies.Alignent's flagship offering, Vision Strategist, is generallyrecognized as the leading application of its kind. The software has aproven track record of helping large organizations improve strategicinnovation planning. Some of the foremost aerospace, defense andhigh-tech companies in the world, including Boeing, BAE Systems,Corning, Honeywell, Lockheed Martin, Motorola and NAVAIR have adoptedAlignent's offering as their product planning solution. £ Alignent's roadmapping software is an ideal complement toSopheon's existing product innovation process and portfolio managementsystem. Vision Strategist allows the user to visualize and predict howexternal market and technology trends will impact product plans overtime, enabling better decisions on future product direction. Aprincipal advantage of the software is that it improvescross-functional communication and collaboration throughout theplanning process. Sopheon's Accolade(R) software enhances theexecution of product plans by automating innovation processgovernance. Although the two applications will continue to be marketedseparately, together they will constitute industry's first end-to-endstrategic product planning software suite. £ The acquisition of Alignent will immediately expand Sopheon'sbusiness in two areas. First, for the company's nearly 100 existingclients in chemical and consumer packaged goods markets, it willextend Sopheon's solution to include strategic product planning.Secondly, Alignent's roster of industry-leading customers will giveSopheon instant credibility in a range of new markets, acceleratingits entry into aerospace, defense and high-tech. £ Sopheon estimates that the acquisition will advance its productplans for Accolade by a full two years. It will also result in asubstantial increase in the size of Sopheon's customer base. Initialfeedback indicates that Sopheon can expect to achieve significantorganic growth by selling its Accolade solution to existing Alignentclients challenged with improving innovation process governance.Sopheon expects to begin offering Accolade's product portfoliomanagement capabilities to Alignent customers this summer. £ "Our acquisition of Alignent represents significant strategicvalue to Sopheon," said Barry Mence, Sopheon's chairman. "It will helpus deepen our penetration in the chemicals and consumer goods marketswe currently target, while accelerating our expansion into new marketssuch as aerospace, defense and high-tech, which offer great upsidegrowth potential. We expect substantial near- and long-term revenuebenefits from the transaction, as well as enhanced earnings on anongoing basis. This is a very positive move for our company, for ourclients and for our shareholders." £ "Sopheon has already established strong market position as thepremier provider of software applications for governance of theinnovation process," said Dennis Clerke, chief executive officer ofAlignent. "The addition of Alignent's products, people and partnerswill enable Sopheon to deliver an unmatched set of strategic productplanning and execution solutions to business and R&D decision makers.This is an exciting development that will yield significant benefitsnot only to Alignent's customers, but to global manufacturers in allsectors of industry." £ Alignent reported revenues of $3 million and a $4.3 million netoperating loss for 2006. Completion of the transaction is contingentupon the receipt of consents from Alignent shareholders and thedelivery of ancillary agreements and formalities. Gross considerationfor the acquisition amounts to $5.5 million, including $4.75 millioninitially upon closing and an additional $750 thousand in potentialearn-out payments. Sopheon expects the Alignent business to make apositive EBITDA contribution from the first year following thepurchase. £ Accolade(R) is a registered trademark of Sopheon plc. £ All other trademarks and registered trademarks are the soleproperty of their respective owners. £ About Alignent Software £ Alignent software company supports the powerful process ofroadmapping. Alignent's solutions dynamically connect product andtechnology planning across the company, empowering organizations tovisualize, manage and communicate future directions within a singlesystem. Alignent focuses R&D efforts, fosters cross-functionalcollaboration and aligns people around a unified plan of record thatadapts in real-time to empower accurate, timely business decisions.The world's most sophisticated product and technology planners rely onAlignent, including BAE Systems, Corning, Honeywell, Lockheed Martin,Medtronic, Motorola, Philips, Textron, the U.S. Air Force and the U.S.Navy. For more information, please visit www.alignent.com. £ About Sopheon £ Sopheon (LSE:SPE) is an international provider of software andservices that help organizations improve the business impact ofproduct innovation. Sopheon's Accolade system automates and governsthe innovation process, enabling companies to increase revenue andprofits from new products. Sopheon is listed on the AIM Market of theLondon Stock Exchange and on the Euronext in the Netherlands. For moreinformation, please visit www.sopheon.com. Copyright Business Wire 2007
Date   Source Headline
27th Jan 20117:00 amPRNTrading Statement
9th Dec 20107:00 amPRNAmendment to the Terms of Convertible Loan Stock
16th Nov 20107:00 amPRNContract Win
4th Nov 20107:00 amPRNInterim Management Statement
27th Aug 201010:30 amPRNGrant of Options
26th Aug 20107:00 amPRNHalf-yearly Report
22nd Jul 20107:00 amRNSTrading Update
15th Jun 20105:31 pmPRNResult of AGM
15th Jun 20107:00 amPRNAGM Statement
18th May 20107:00 amRNSAfton Chemical Selects Idea Lab
6th May 20107:00 amPRNInterim Management Statement
25th Mar 20107:00 amPRNFinal Results
22nd Mar 20107:00 amRNSiSUSTAINT Alliance Launched
3rd Feb 20107:00 amRNSSopheon Team wins TARDEC Contract
28th Jan 20107:00 amPRNTrading Update
24th Dec 20097:01 amRNSExtension of GEM Equity Line
2nd Dec 20097:00 amRNSVision Strategist Version 5.0 Launched
3rd Nov 20097:00 amPRNInterim Management Statement
2nd Oct 20093:43 pmPRNISSUE OF CONVERTIBLE LOAN STOCK
27th Aug 20097:00 amPRNHalf-yearly Report
16th Jun 200912:34 pmPRNResult of AGM
16th Jun 20097:00 amPRNAGM Statement
19th May 20097:00 amPRNProduct Launch
7th May 20097:00 amPRNInterim Management Statement
26th Mar 20097:00 amPRNFinal Results
18th Mar 20097:00 amRNSBostik Implements Sopheon's Accolade System
11th Mar 20097:00 amRNSContract Win
11th Feb 20097:00 amRNSEnhanced Version of Accolade? Launched
28th Jan 20097:00 amPRNTrading Update
21st Jan 20097:00 amRNSSopheon Partners with Maxsoft
4th Nov 20087:00 amPRNInterim Management Statement
28th Aug 20087:00 amPRNHalf-yearly Report
27th Jun 20083:47 pmPRNDirector/PDMR Shareholding
25th Jun 20087:00 amPRNGrowth Milestone
10th Jun 20087:00 amPRNAGM Statement
16th May 20087:00 amPRNDirector/PDMR Shareholding
15th May 20087:00 amPRNInterim Management Statement
6th May 200810:00 amPRNNotice of AGM
29th Apr 20087:02 amRNSContract Win
1st Apr 200810:00 amPRNGrant of Options
27th Mar 20087:00 amPRNFinal Results
6th Feb 20087:01 amRNSProduct Development
25th Jan 20087:00 amPRNTrading Update
21st Dec 200710:30 amPRNTrading Update
25th Oct 20077:00 amPRNTrading Update
16th Oct 20072:38 pmBUSBeiersdorf Implements Sopheon System in Support of Product Innovation Strategy
16th Oct 20077:01 amRNSContract Win
10th Oct 20072:45 pmBUSLeading European Center for Clinical Trials Research Selects Sopheon's Accolade(R) System
10th Oct 20077:01 amRNSContract Win
1st Oct 20077:02 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.